January 13, 2025: WHO warns about a fake cancer drug with English packaging

January 13, 2025

WHO reported a fake cancer treatment. This year’s Notorious Markets report focused on fake online pharmacies. Board member Andrea Thomas urged fraternities to stock Narcan.

January 6, 2025: Counterfeit pills are increasingly available globally and their contents are ever more unpredictable

January 6, 2025

As prescription medications containing fentanyl and other illegal substances are becoming more widely accessible worldwide, a global crackdown on illicit drug precursors is leading cartels to experiment with the contents of their products.

FDA Alert: Recall Issued on “Herbal” Diet Pill Containing Prescription and OTC Drug Ingredients

December 17, 2024

FDA analysis has found these products to contain undeclared Furosemide, Dexamethasone and Chlorpheniramine. Furosemide was found at 5.24 mg/g or 1.84 mg/capsule. Dexamethasone was found at 2.22 mg/g or 0.780 mg/capsule. Chlorpheniramine was found at 4.38 mg/g or 1.54 mg/capsule.

December 16, 2024: Black market medicine in Texas and Tennessee

December 16, 2024

Two new cases involving black market medicine in Texas and Tennessee, and CPB seized thousands of pills in Laredo.

December 9, 2024: Lawsuit against Snap to proceed

December 9, 2024

The lawsuit against Snap may proceed and the ADA issued a statement about compounded GLP-1 medicines.

December 2, 2024: Black market HIV drug trafficking costs criminal $31 million in restitution

December 3, 2024

A California man must pay millions in restitution for selling fake HIV meds. Additional news about Virginia’s state drug importation plans, prosecutions around fentanyl pills, and overseas incidents.

November 25, 2024: A new money laundering case is tied to online pharmacies selling counterfeit pills

November 25, 2024

A California man allegedly processed payments for foreign online pharmacies selling fentanyl and meth pills.

November 18, 2024: Regulators struggle with GLP-1s in the U.S. and abroad

November 18, 2024

Novo Nordisk filed five more lawsuits against businesses selling compounded semaglutide. Dr. Tim Mackey spoke about the dangers of the unregulated semaglutide sales online, and South Africa warned residents about counterfeit Ozempic.

FDA Alert: Dietary Supplement Recalled Due to Presence of Sildenafil and Diclofenac

November 14, 2024

Consumption of products with undeclared sildenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life threatening. People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Among the adult male population, who are most likely to use this product, adult males who use nitrates for cardiac conditions are most at risk.

FDA Alert: Dietary Supplement Contains Drug That Can Cause Heart Attack, Stroke and Internal Bleeding

November 14, 2024

Use of products with undeclared diclofenac may cause increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration, and fatal perforation of the stomach and intestines. This hidden drug ingredient may also interact with other medications and significantly increase the risk of adverse events, particularly when consumers use multiple NSAID-containing products.